Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills
  1. Research Outputs

Efficacy of Hylan G-F 20 versus 6-methylprednisolone acetate in painful shoulder osteoarthritis: A retrospective controlled trial

Academic Article
Publication Date:
2011
Short description:
Efficacy of Hylan G-F 20 versus 6-methylprednisolone acetate in painful shoulder osteoarthritis: A retrospective controlled trial / Merolla, Giovanni; Sperling, John W.; Paladini, Paolo; Porcellini, Giuseppe. - In: MUSCULOSKELETAL SURGERY. - ISSN 2035-5106. - 95:3(2011), pp. 215-224. [10.1007/s12306-011-0138-3]
abstract:
Shoulder osteoarthritis affect about 32% of patients over 60 years. Conservative treatment are recommended to restore shoulder function while shoulder arthroplasty remains the standard treatment for severe osteoarthritis. When conservative therapies fail and surgical approach is precluded, viscosupplementation with HA may be the treatment of choice. Currently, there is minimal information available comparing the results of Hylan G-F 20 and corticosteroid injections for the treatment of shoulder osteoarthritis. Therefore, the purpose of this study was to examine the results of these two treatments at specific time points with validated outcome measurements. Retrospective comparative cohort study. The study population included 84 patients, 51 of whomtreated with Hylan G-F 20 and 33 with a corticosteroid. Gleno-humeral osteoarthritis was graded according to Samilson-Prieto classification and rotator cuff was assessed with MRI. Both groups received three injections 1 week apart and were evaluated using a Visual Analog Scale (VAS) for pain and satisfaction, the Shoulder Pain and Disability Index (SPADI) and the Constant-Murley scale. Outcomes were registered at 1, 3, and 6 months. The Hylan G-F 20 group showed a significant pain reduction (P<0.05), improvement in the Constant-Murley, SPADI scores (P<0.05), and satisfaction (P<0.01) at all three follow-up times. Pain, clinical scores, and subjective satisfaction in the corticosteroid group improved in the first post treatment month only (P<0.05) compared with the baseline. Overall, lower clinical advantages were found in patients with greater degree of osteoarthritis and rotator cuff tears. Intra-articular injections with Hylan G-F 20 are effective in reducing pain for up to 6 months in gleno-humeral osteoarthritis whereas corticosteroids injections resulte in improvement at 1 month only. In patients with severe osteoarthritis and/or full-thickness, RC tears results tended to be worse. © 2011 Springer-Verlag.
Iris type:
Articolo su rivista
Keywords:
Corticosteroids; Hyaluronic acid; Injection; Osteoarthritis; Shoulder; Aged; Anti-Inflammatory Agents; Biocompatible Materials; Female; Humans; Hyaluronic Acid; Injections, Intra-Articular; Male; Methylprednisolone; Middle Aged; Osteoarthritis; Retrospective Studies; Severity of Illness Index; Shoulder Pain; Surgery; Orthopedics and Sports Medicine
List of contributors:
Merolla, Giovanni; Sperling, John W.; Paladini, Paolo; Porcellini, Giuseppe
Authors of the University:
PORCELLINI Giuseppe
Handle:
https://iris.unimore.it/handle/11380/1160278
Published in:
MUSCULOSKELETAL SURGERY
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.4.5.0